Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Chiou Ling Cheng"'
Autor:
Yi-Jing Hsiao, Su-Chien Chiang, Chih-Hsien Wang, Nai-Hsin Chi, Hsi-Yu Yu, Tsai-Hsia Hong, Hsuan-Yu Chen, Chien-Yu Lin, Shuenn-Wen Kuo, Kang-Yi Su, Wen-Je Ko, Li-Ming Hsu, Chih-An Lin, Chiou-Ling Cheng, Yan-Ming Chen, Yih-Sharng Chen, Sung-Liang Yu
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-14 (2024)
Abstract Objective As the global use of extracorporeal membrane oxygenation (ECMO) treatment increases, survival rates have not correspondingly improved, emphasizing the need for refined patient selection to optimize resource allocation. Currently, p
Externí odkaz:
https://doaj.org/article/57c3ed14071a4272b5c84ba0c00d414b
Autor:
Yue Leon Guo, Ming-Chieh Li, Yu-Chen Chuang, Chiou-Ling Cheng, Bing-Ching Ho, Sung-Liang Yu, Kang-Yi Su, Nian-Wei Lee
Publikováno v:
Environmental Research. 170:481-486
Epigenome-wide DNA methylation has not been studied in men perinatally exposed to PCBs and dioxins. Therefore, we examined whether perinatal exposure to polychlorinated biphenyls (PCBs) and polychlorinated dibenzofurans (PCDFs) induces sustained meth
Autor:
Chiou-Ling Cheng, Huei-Wen Chen, Tsung-Ying Yang, Ker-Chau Li, Gee-Chen Chang, Sheng-Fang Su, Jeng-Sen Tseng, Chia Hsin Liu, Sung-Liang Yu, Kuo-Hsuan Hsu, Chao-Chi Ho, Kun-Chieh Chen
Publikováno v:
JCO Precision Oncology
PURPOSE Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) show efficacy in treating patients with lung adenocarcinoma with EGFR-activating mutations. However, a significant subset of targeted patients fail to respond. Unlike a
Autor:
Chia Hsin Liu, Chiou Ling Cheng, Ya Hsuan Chang, Hsuan-Yu Chen, Poyin Huang, Jin-Shing Chen, Bing Ching Ho, Kang-Yi Su, Gee-Chen Chang, Yi Chiung Hsu, Sung-Liang Yu
Publikováno v:
Oncotarget
// Poyin Huang 1, 2, 3, 4 , Chiou-Ling Cheng 5 , Ya-Hsuan Chang 6 , Chia-Hsin Liu 6 , Yi-Chiung Hsu 6 , Jin-Shing Chen 7 , Gee-Chen Chang 8, 9, 10 , Bing-Ching Ho 5 , Kang-Yi Su 5 , Hsuan-Yu Chen 6 , Sung-Liang Yu 5, 11, 12, 13, 14 1 Department of Ne
Autor:
Shinsheng Yuan, Jin-Yuan Shih, Tai Ching Lin, Yi Chiung Hsu, Ker-Chau Li, Tsung Ying Yang, Huei-Wen Chen, Gee-Chen Chang, Kuo-Hsuan Hsu, Kang-Yi Su, Chung Ping Hsu, Kang Chung Yang, Yih-Leong Chang, Pan-Chyr Yang, Jiun Yi Hsia, Chiou Ling Cheng, Hsuan-Yu Chen, Chu Chun Hsu, Sung-Liang Yu, Chien-Yu Lin, Jeremy J.W. Chen, Yi Wei Chen, Chin Di Wang, Guani Wu, Chih Yi Chen, Chong-Jen Yu, Kun Cheieh Chen, Yi Ling Lai, Chia Hsin Liu
Publikováno v:
Journal of Clinical Oncology. 29:3435-3442
Purpose Although epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been proven more effective for patients with lung adenocarcinoma with EGFR-activating mutation rather than wild type, the former group still includes appr
Autor:
Chiou Ling Cheng, J. Cheng, Yuan Huei Chang, Yang-Fang Chen, Hsueh-Yu Chao, Ming-Wen Chu, Chin-Hsiung Hsu
Publikováno v:
Applied Physics A. 97:79-83
Oriented CdSe nanobelts and nanorods were grown successfully on GaAs and Si substrates by metal organic chemical vapor deposition. The thickness of Au film coated on the substrate plays an important role in determining the orientation, size, and dens
Autor:
Pan-Chyr Yang, Ang Yuan, Hsuan-Yu Chen, Chiou Ling Cheng, Sher Singh, Jeremy J.W. Chen, Wing Kai Chan, Gee-Chen Chang, C.-H. Wang, Liu Cc, Sung-Liang Yu, Li Hn, H.-J. Terng, Chih Yi Chen, Wei J. Chen, S.-F. Kao, Chun-Houh Chen
Publikováno v:
New England Journal of Medicine. 356:11-20
BACKGROUND Current staging methods are inadequate for predicting the outcome of treatment of non-small-cell lung cancer (NSCLC). We developed a five-gene signature that is closely associated with survival of patients with NSCLC. METHODS We used compu
Autor:
Chong-Jen Yu, Qi Sheng Hong, Wei J. Chen, Liu Cc, Te Jen Su, Sher Singh, Gee-Chen Chang, Ker-Chau Li, Han Shiang Chen, Huei-Wen Chen, Jeremy J.W. Chen, Hsin Yuan Su, Yung Chie Lee, Chiou Ling Cheng, Wing Kai Chan, Sung-Liang Yu, Wan Jiun Chen, Li Hn, Chih Yi Chen, Hsuan-Yu Chen, Pan-Chyr Yang, Chun Chieh Chen, Ching Cheng Chiang
Publikováno v:
Cancer cell. 13(1)
SummaryWe investigated whether microRNA expression profiles can predict clinical outcome of NSCLC patients. Using real-time RT-PCR, we obtained microRNA expressions in 112 NSCLC patients, which were divided into the training and testing sets. Using C
Publikováno v:
Cancer Research. 75:3075-3075
Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide. Metastasis, the spread process of cancer cells from a primary tumor to seed secondary tumors in distant sites, is one of the big challenges in cancer treatment today.
Autor:
Yuh-Shan Jou, Wing Kai Chan, Chiou Ling Cheng, Chung-Wu Lin, Meng-Feng Tsai, Pan-Chyr Yang, Chun-Yi Wu, Chi Chung Wang, Wei J. Chen, Yu Ping Yang, Hsuan-Yu Chen, Shu Chen Lin, Hsiu Ping Lin, Jeremy J.W. Chen, Gee-Chen Chang, Chih Yi Chen, Fu Yuan Shih, Liu Cc
Publikováno v:
Journal of the National Cancer Institute. 98(12)
Non – small-cell lung carcinoma (NSCLC) is the predominant type of lung cancer ( 3 ) . Approximately 30% of patients with NSCLC are diagnosed at an early stage of the disease and receive curative surgery. However, disease will recur within 5 years